

NCT02624908 Raw comparison:

Summary:
CHIA has 20 criteria while your personal folder has 22 criteria
Total found criteria: 20/20
Total not Found: 0/20
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ use of basal-bolus insulin                         │ use of basal-bolus insulin                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ onset of diabetes after age 30                     │ onset of diabetes after age 30                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ BMI less than 35                                   │ BMI less than 35                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ eGFR at least 60 ml/mn                             │ eGFR at least 60 ml/mn                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hb A1c 7 0-10 0%                                   │ Hb A1c 7 0-10 0%                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ willingness to perform home glucose monitoring     │ willingness to perform home glucose monitoring     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ willingness to transmit glucose and medication     │ willingness to transmit glucose and medication     │
│ information weekly                                 │ information weekly                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Type 1 diabetes                                    │ Type 1 diabetes                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known peripheral artery disease                    │ Known peripheral artery disease                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Liver enzymes equal or more than 1 5 times the     │ Liver enzymes equal or more than 1 5 times the     │
│ upper limit of normal                              │ upper limit of normal                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Chronic heart failure NYHA class III or IV         │ Chronic heart failure NYHA class III or IV         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current haemodialysis or peritoneal dialysis       │ Current haemodialysis or peritoneal dialysis       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ End stage liver disease defined as acute or        │ End stage liver disease defined as acute or        │
│ chronic liver disease and recent history of one of │ chronic liver disease and recent history of one of │
│ the following ascites encephalopathy variceal      │ the following ascites encephalopathy variceal      │
│ bleeding bilirubin equal or greater than 2 0 mg/dL │ bleeding bilirubin equal or greater than 2 0 mg/dL │
│ albumin equal or less than 3 5 g/ dL prothrombin   │ albumin equal or less than 3 5 g/ dL prothrombin   │
│ time greater or equal to 4 seconds INR greater     │ time greater or equal to 4 seconds INR greater     │
│ than or equal to 1 7 or prior liver transplant     │ than or equal to 1 7 or prior liver transplant     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known or suspected hypersensitivity to trial       │ Known or suspected hypersensitivity to trial       │
│ products or related products                       │ products or related products                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Female of child-bearing potential who is pregnant  │ Female of child-bearing potential who is pregnant  │
│ breast-feeding or intends to become pregnant or is │ breast-feeding or intends to become pregnant or is │
│ not using adequate contraceptive methods as        │ not using adequate contraceptive methods as        │
│ required by law or local practice                  │ required by law or local practice                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Expected simultaneous participation in any other   │ Expected simultaneous participation in any other   │
│ clinical trial of an investigational medicinal     │ clinical trial of an investigational medicinal     │
│ product                                            │ product                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Receipt of any investigational medicinal product   │ Receipt of any investigational medicinal product   │
│ within 30 days before randomization                │ within 30 days before randomization                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current or past (within the last 5 years)          │ Current or past (within the last 5 years)          │
│ malignant neoplasms (except basal cell and         │ malignant neoplasms (except basal cell and         │
│ squamous cell skin carcinoma)                      │ squamous cell skin carcinoma)                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any condition that in the investigator's opinion   │ Any condition that in the investigator's opinion   │
│ would make the subject unable to adhere to the     │ would make the subject unable to adhere to the     │
│ trial visit schedule and procedures                │ trial visit schedule and procedures                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known history of non-compliance to treatment       │ Known history of non-compliance to treatment       │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have maximum age of 70 Years │
├───────────────────────────────────┤
│ Must have minimum age of 30 Years │
╘═══════════════════════════════════╛